Patterns of polyomavirus SV40 infections and associated cancers in humans: A model

Current Opinion in Virology

Volumn 2, Issue 4, 2012, Pages 508-514

  Butel, Janet S ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLIOMYELITIS VACCINE;

ARTICLE; DEMOGRAPHY; DRUG CONTAMINATION; HUMAN; HYGIENE; LYMPHOMA; NEOPLASM; NONHUMAN; POLYOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; SIMIAN VIRUS 40; SIMIAN VIRUS 40 INFECTION; VIRUS LIKE AGENT; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 84865129508     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2012.06.004     Document Type: Review

References (42)

1. K. Shah, and N. Nathanson Human exposure to SV40: review and comment American Journal of Epidemiology 103 1976 1 12 This historic paper provides a detailed description of how poliovaccines were contaminated with SV40, estimates of the extent of that contamination, and exposures to contaminated inactivated vaccines in the United States in the late 1950s.
2. J.A. Vanchiere, R.K. Nicome, J.M. Greer, G.J. Demmler, and J.S. Butel Frequent detection of polyomaviruses in stool samples from hospitalized children Journal of Infectious Diseases 192 2005 658 664 (Pubitemid 41099315)
3. M. Babakir-Mina, M. Ciccozzi, C. Alteri, P. Polchi, A. Picardi, F. Greco, G. Lucarelli, W. Arcese, C.F. Perno, and M. Ciotti Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disorders Journal of Medical Virology 81 2009 1668 1673
4. A.S.Y. Wong, V.C.C. Cheng, K.-Y. Yuen, Y.-L. Kwong, and A.Y.H. Leung High frequency of polyoma BK virus shedding in the gastrointestinal tract after hematopoietic stem cell transplantation: a prospective and quantitative analysis Bone Marrow Transplantation 43 2009 43 47
5. J.A. Vanchiere, S. Abudayyeh, C.M. Copeland, L.B. Lu, D.Y. Graham, and J.S. Butel Polyomavirus shedding in the stool of healthy adults Journal of Clinical Microbiology 47 2009 2388 2391 Polyomaviruses BKV, JCV, and SV40 were detected in stool samples from healthy adults, but at a shedding frequency lower than observed previously for children. These findings in adults, together with observations in children, suggest a fecal-oral route is likely for transmission of polyomavirus infections.
6. S. Bialasiewicz, D.M. Whiley, S.B. Lambert, M.D. Nissen, and T.P. Sloots Detection of BK, JC WU, or KI polyomaviruses in faecal, urine, blood, cerebrospinal fluid and respiratory samples Journal of Clinical Virology 45 2009 249 254
7. S. Bofill-Mas, M. Formiga-Cruz, P. Clemente-Casares, F. Calafell, and R. Girones Potential transmission of human polyomaviruses through the gastrointestinal tract after exposure to virions or viral DNA Journal of Virology 75 2001 10290 10299 (Pubitemid 32948059)
8. S.M. McQuaig, T.M. Scott, V.J. Harwood, S.R. Farrah, and J.O. Lukasik Detection of human-derived fecal pollution in environmental waters by use of a PCR-based human polyomavirus assay Applied and Environmental Microbiology 72 2006 7567 7574 (Pubitemid 44927658)
9. S. Bofill-Mas, J. Rodriguez-Manzano, B. Calgua, A. Carratala, and R. Girones Newly described human polyomaviruses Merkel cell, KI and WU are present in urban sewage and may represent potential environmental contaminants Virology Journal 7 2010 e141
10. W. Ahmed, C. Wan, A. Goonetilleke, and T. Gardner Evaluating sewage-associated JCV and BKV polyomaviruses for sourcing human fecal pollution in a coastal river in Southeast Queensland, Australia Journal of Environmental Quality 39 2010 1743 1750
11. J.L. Melnick, and S. Stinebaugh Excretion of vacuolating SV-40 virus (papova virus group) after ingestion as a contaminant of oral poliovaccine Proceedings of the Society for Experimental Biology and Medicine 109 1962 965 968 This paper was the first description of fecal shedding of SV40. It involved infants fed SV40-contaminated oral poliovaccine.
12. J.R. Paul A History of Poliomyelitis 1971 Yale University Press New Haven
13. J.L. Melnick Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses B.N. Fields, D.M. Knipe, R.M. Chanock, J.L. Melnick, B. Roizman, R.E. Shope, Virology 1985 Raven Press New York 739 794
14. A.B. Sabin Perspectives on rapid elimination and ultimate global eradication of paralytic poliomyelitis caused by polioviruses European Journal of Epidemiology 7 1991 95 120
15. D.Y. Graham H. Menge, M. Gregor, G.N.J. Tytgat, B.J. Marshall, C.A.M. McNulty, Helicobacter pylori in human populations: the present and predictions of the future based on the epidemiology of polio 1991 Springer-Verlag Berlin 97 102
16. S.M. Feinstone, and I.D. Gust Hepatitis A virus D.D. Richman, R.J. Whitley, F.G. Hayden, Clinical Virology edn 2 2002 ASM Press Washington, DC 1019 1039
17. Z.Z. Nurgalieva, H.M. Malaty, D.Y. Graham, R. Almuchambetova, A. Machmudova, D. Kapsultanova, M.S. Osato, F.B. Hollinger, and A. Zhangabylov Helicobacter pylori infection in Kazakhstan: effect of water source and household hygiene American Journal of Tropical Medicine and Hygiene 67 2002 201 206 (Pubitemid 135715337)
18. R. Cutrone, J. Lednicky, G. Dunn, P. Rizzo, M. Bocchetta, K. Chumakov, P. Minor, and M. Carbone Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961 Cancer Research 65 2005 10273 10279 (Pubitemid 41743719)
19. Pan American Sanitary Bureau Pan American Sanitary Bureau First International Conference on Live Poliovirus Vaccines (Washington, DC, 22-26 June 1959). Papers Presented and Discussions Held 1959 Pan American Sanitary Bureau, Scientific Publication No. 44 Washington, DC
20. Pan American Sanitary Bureau Pan American Sanitary Bureau Second International Conference on Live Poliovirus Vaccines (Washington, DC, 6-10 June 1960). Papers Presented and Discussions Held 1960 Pan American Sanitary Bureau, Scientific Publication No. 50 Washington, DC
21. A.B. Sabin Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world Journal of Infectious Diseases 151 1985 420 436 (Pubitemid 15103791)
22. H. Koprowski First decade (1950-1960) of studies and trials with the polio vaccine Biologicals 34 2006 81 86 (Pubitemid 43765783)
23. J.S. Butel Polyomavirus SV40: model infectious agent of cancer E. Robertson, Cancer Associated Viruses 2012 Springer Science 377 417
24. C. Frank, M.K. Mohamed, G.T. Strickland, D. Lavanchy, R.R. Arthur, L.S. Magder, T. El Khoby, Y. Abdel-Wahab, E.S.A. Ohn, W. Anwar, and I. Sallam The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt Lancet 355 2000 887 891 (Pubitemid 30137669)
25. F. Rapp, J.L. Melnick, J.S. Butel, and T. Kitahara The incorporation of SV40 genetic material into adenovirus 7 as measured by intranuclear synthesis of SV40 tumor antigen Proceedings of the National Academy of Sciences of the United States of America 52 1964 1348 1352
26. A.M. Lewis Jr. SV40 in adenovirus vaccines and adenovirus-SV40 recombinants Developments in Biological Standardization 94 1998 207 216
27. K.V. Shah, D.A. Galloway, W.A. Knowles, and R.P. Viscidi Simian virus 40 (SV40) and human cancer: a review of the serological data Reviews in Medical Virology 14 2004 231 239 (Pubitemid 38879815)
28. J.M. Kean, S. Rao, M. Wang, and R.L. Garcea Seroepidemiology of human polyomaviruses PLoS Pathogens 5 2009 e1000363
29. A. Corallini, E. Mazzoni, A. Taronna, M. Manfrini, G. Carandina, G. Guerra, R. Guaschino, F. Vaniglia, C. Magnani, and F. Casali Specific antibodies reacting with simian virus 40 capsid protein mimotopes in serum samples from healthy blood donors Human Immunology 73 2012 502 510 An immunoassay was developed based on SV40-specific peptides from viral capsid proteins VP1 and VP2/3. Antibodies were detected in healthy blood donors able to react with both peptides, suggesting the SV40-specificity of those reactions.
30. V. Bouvard, R.A. Baan, Y. Grosse, B. Lauby-Secretan, F. El Ghissassi, L. Benbrahim-Tallaa, N. Guha, K. Straif on behalf of the WHO International Agency for Research on Cancer Monograph Working Group Carcinogenicity of malaria and of some polyomaviruses Lancet Oncology 13 2012 339 340
31. J.S. Butel, and J.A. Lednicky Cell and molecular biology of simian virus 40: implications for human infections and disease Journal of the National Cancer Institute 91 1999 119 134 (Pubitemid 29042689)
32. K. Stratton, D.A. Almario, and M.C. McCormick Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer 2003 The National Academies Press Washington, DC
33. M.K. White, and K. Khalili Polyomaviruses and human cancer: molecular mechanisms underlying patterns of tumorigenesis Virology 324 2004 1 16 (Pubitemid 38737394)
34. J.S. Butel Simian virus 40, human infections, and cancer: emerging concepts and causality considerations K. Khalili, K.T. Jeang, Viral Oncology: Basic Science and Clinical Applications 2010 Wiley-Blackwell Hoboken, NJ 165 189 This review identifies sets of criteria proposed in the past to establish viral causation of human cancer and evaluates the status of evidence associating SV40 with human neoplasia. Complete listings and references are provided for controlled studies that used molecular techniques to detect SV40 DNA in brain tumors, mesotheliomas, and lymphomas.
35. A.N. Zekri, A.A. Bahnassy, W.S. Mohamed, N. Hassan, A.M. Abdel-Rahman, F.A. El-Kassem, and R. Gaafar Evaluation of simian virus-40 as a biological prognostic factor in Egyptian patients with malignant pleural mesothelioma Pathology International 57 2007 493 501 (Pubitemid 47030133)
36. S. Toracchio, C.A. Kozinetz, D.E. Killen, A.M. Sheehan, E.I. Banez, M.M. Ittmann, V. Sroller, and J.S. Butel Variable frequency of polyomavirus SV40 and herpesvirus EBV in lymphomas from two different urban population groups in Houston, TX Journal of Clinical Virology 46 2009 154 160 The frequency of SV40 positivity in lymphomas was shown to differ significantly between samples obtained from two hospitals in Houston, TX that served populations with different demographics. This was the first demonstration, in a direct comparison using the same methodologies, that the prevalence of SV40 DNA in cancer specimens can differ significantly among population groups.
37. A. Meneses, D. Lopez-Terrada, P. Zanwar, D.E. Killen, V. Monterroso, J.S. Butel, and R.A. Vilchez Lymphoproliferative disorders in Costa Rica and simian virus 40 Haematologica 90 2005 1635 1642 (Pubitemid 41814987)
38. H.D. Strickler, P.S. Rosenberg, S.S. Devesa, J. Hertel, J.F. Fraumeni Jr., and J.J. Goedert Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates The Journal of the American Medical Association 279 1998 292 295 (Pubitemid 28071020)
39. H.D. Strickler, J.J. Goedert, S.S. Devesa, J. Lahey, J.F. Fraumeni Jr., and P.S. Rosenberg Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines Journal of the National Cancer Institute 95 2003 38 45 (Pubitemid 36124294)
40. E.A. Engels, H.A. Katki, N.M. Nielsen, J.F. Winther, H. Hjalgrim, F. Gjerris, P.S. Rosenberg, and M. Frisch Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40 Journal of the National Cancer Institute 95 2003 532 539 (Pubitemid 36511624)
41. E.A. Engels, L.H. Rodman, M. Frisch, J.J. Goedert, and R.J. Biggar Childhood exposure to simian virus 40-contaminated poliovirus vaccine and risk of AIDS-associated non-Hodgkin's lymphoma International Journal of Cancer 106 2003 283 287 (Pubitemid 36835184)
42. D.E.M. Rollison Epidemiologic studies of polyomaviruses and cancer: previous findings, methodologic challenges and future directions N. Ahsan, Polyomaviruses and Human Diseases 2006 Landes Biosciences Georgetown, TX 342 356